Lanlan Pang

机构：Sun Yat-sen University, Sun Yat-sen University Cancer Center · ORCID：0000-0002-4932-8117

发表论文 64 篇 · 总被引 527 次 · h-index 13

代表论文

• Chemotherapy-Based Combination Regimens for Advanced EGFR-Mutant NSCLC After EGFR-TKI Failure: A Network Meta-Analysis (2025 · Journal of the National Comprehensive Cancer Network · 被引 7)
• Rare transformation from lung adenocarcinoma to sarcomatoid carcinoma mediates resistance to inhibitors targeting different driver oncogenes (2024 · Journal of the National Cancer Center · 被引 5)
• Immunotherapy efficacy between exon 19 deletion and exon 21 L858R mutation in advanced EGFR mutant non-small-cell lung cancer: a direct and indirect meta-analysis (2025 · Translational Lung Cancer Research · 被引 3)
• Specifying the choice of EGFR-TKI based on brain metastatic status for advanced NSCLC with EGFR p.L861Q mutation (2024 · Neoplasia · 被引 3)
• Activating NEDD4L suppresses EGFR-driven lung adenocarcinoma growth via facilitating EGFR proteasomal degradation (2025 · Journal of Experimental & Clinical Cancer Research · 被引 2)
• Impaired TGF-β signaling via AHNAK family mutations elicits an esophageal cancer subtype with sensitivities to genotoxic therapy and immunotherapy (2024 · Cancer Immunology Immunotherapy · 被引 2)